Marco Occhiuto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Marco Occhiuto has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Cristiana Cipriani
Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy
2 shared publications - Jessica Pepe
Department of Medical and Cardiovascular Sciences, “Sapienza” University of Rome, Rome, Italy
2 shared publications - Luciano Colangelo
Department of Medical and Cardiovascular Sciences, Sapienza University, Rome, Italy.
2 shared publications - Salvatore Minisola
Department of Clinical, Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy
2 shared publications - Viviana De Martino
Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences (SCIAC), “Sapienza” University of Rome, 00161 Rome, Italy
2 shared publications - Alfredo Scillitani
Unit of Endocrinology, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo (FG), Italy
1 shared publication
Latest Publications
- 24 July 2026
- Published by Taylor & Francis in Future Microbiology
- Vol. 21 (11) , 1059-1064
Capnocytophaga canimorsus spondylodiscitis: an unusual presentation of a zoonotic infection
1. Capnocytophaga canimorsus is a capnophilic, slow-growing, Gram-negative bacillus and a true commensal of the oral microbiota of dogs and cats, with carriage rates in healthy animals reported at ...
- 24 July 2026
- Published by Taylor & Francis in Future Microbiology
- Vol. 21 (11) , 1059-1064
Capnocytophaga canimorsus spondylodiscitis: an unusual presentation of a zoonotic infection
1. Capnocytophaga canimorsus is a capnophilic, slow-growing, Gram-negative bacillus and a true commensal of the oral microbiota of dogs and cats, with carriage rates in healthy animals reported at ...
- Open Access
Effect of 2 Years of Monthly Calcifediol Administration in Postmenopausal Women with Vitamin D Insufficiency
Background: We assessed the long-term (24 months) efficacy and safety of monthly calcifediol (0.266 mg) in the correction and maintenance of total 25(OH)D levels in postmenopausal women with basal values p for trend < 0.001). However, mean values at month 24 (36.7 ± 15.9) were not significantly different in respect to values at month 12 (41.2 ± 11.18). At 24 months, only 1 out 19 patients had a value p < 0.0216), with no significant changes between 12 and 24 months. No significant changes were observed as far as ionised calcium or creatinine were concerned. Conclusions: The long-term administration of calcifediol maintains stable and sustained 25(OH)D concentrations, with no safety concerns.
Open AccessEffect of 2 Years of Monthly Calcifediol Administration in Postmenopausal Women with Vitamin D Insufficiency
Background: We assessed the long-term (24 months) efficacy and safety of monthly calcifediol (0.266 mg) in the correction and maintenance of total 25(OH)D levels in postmenopausal women with basal values p for trend < 0.001). However, mean values at month 24 (36.7 ± 15.9) were not significantly different in respect to values at month 12 (41.2 ± 11.18). At 24 months, only 1 out 19 patients had a value p < 0.0216), with no significant changes between 12 and 24 months. No significant changes were observed as far as ionised calcium or creatinine were concerned. Conclusions: The long-term administration of calcifediol maintains stable and sustained 25(OH)D concentrations, with no safety concerns.
- Open Access
- 15 June 2022
- Published by Elsevier in Bone Reports
- Vol. 16, 101230
Short term effects of different doses of cholecalciferol on circulating levels of 24,25(OH)2D
- 15 June 2022
- Published by Elsevier in Bone Reports
- Vol. 16, 101230
Open AccessShort term effects of different doses of cholecalciferol on circulating levels of 24,25(OH)2D